SBIR / NIH · Mar 2025
NIH SBIR award for Humidifeye; public award page lists a $1,220,683 grant and a 2025 start date.
Responsive materials, better lives.
Company research
Public company, workplace, funding, and market signals
Overview
AesculaTech is a Los Angeles-based biotechnology/materials science startup developing custom, temperature-responsive smart materials for biomedical, consumer, and industrial uses, with Humidifeye as its flagship dry-eye product.
Primary product
Humidifeye — a smart gel punctal plug / dry-eye treatment platform
Founded
2016
Headquarters
1010 Wilshire Blvd, Los Angeles, CA 90017, USA
Team size
1-10
Industry
Biotechnology Research
Sub-industry
Smart materials / ophthalmic medical devices
Offices
1010 Wilshire Blvd, Los Angeles, CA 90017, USA
Business model
partnership-led commercialization
licensing
medical device development
Funding
Stage
seed
Latest round
SBIR Grant · Mar 2025
Latest amount
$1.2M
People & investors
Leadership
Co-founder & Chief Executive Officer
Founders
Co-founder
Work & culture
Mission-driven and science-heavy, emphasizing custom chemistry, responsive materials, and partnerships to build patient-friendly products that improve health outcomes.
Product & market
Differentiators
- —temperature-responsive smart materials that change state with heat
- —customizable platform tuned for biocompatibility and material strength
- —patient-friendly, reversible punctal plug behavior
- —broader platform applications beyond dry eye across medical/consumer/industrial sectors
- —partnership-oriented commercialization model
Technology
Google Workspace
Impact
Asana
C
Podium
Customers
healthcare partners
ophthalmologists
optometrists
consumer goods partners
industrial partners
academia / research collaborators
Competitors
conventional punctal plugs
prescription dry-eye drops (e.g., Restasis, Xiidra)
over-the-counter lubricating eye drops
other ocular drug-delivery / dry-eye device developers
Scale & contact
Estimated revenue
Estimated ~$5M ARR (third-party estimate, 2024)
Estimated monthly visits
1.2K
Traffic estimate as of Jun 2026
Latest news
ClinicalTrials.gov · Feb 2024
Clinical trial registry page shows the AesculaTech-sponsored canalicular occlusion study was completed on 2024-02-22.
AesculaTech · Sep 2023
Company says Humidifeye received a fast-track SBIR award worth over $1.5M from the NIH National Eye Institute.
AesculaTech · Aug 2023
Company reported a 22-patient, 3-month first-in-human pilot with safety and symptom improvements.
Jobs and careers at AesculaTech
0 jobs at AesculaTech
No open positions
Check back later for new openings